Solara Active News Today

On Monday, 2025 stocks advanced, 1661 declined and 201 remained unchanged, with an advance decline ratio of 1.22 on the Bombay Stock Exchange (BSE), indicating a positive closing of stocks in broader markets. Strong results in the pharma and IT industries helped the Indian market start the week with modest gains. The market was cautious due to the upcoming release of inflation data and the RBIs monetary policy.

On Monday, 2025 stocks advanced, 1661 declined and 201 remained unchanged, with an advance decline ratio of 1.22 on the Bombay Stock Exchange (BSE), indicating a positive closing of stocks in broader markets. Strong results in the pharma and IT industries helped the Indian market start the week with modest gains. The market was cautious due to the upcoming release of inflation data and the RBIs monetary policy.

After a week filled with better-than-expected quarterly earnings report of giant firms like TVS, HDFC, etc, stock market investors will be keenly waiting for Q4 report of Tata Motors, Canara Bank, HAL, DLF, Vedanta, and others next week

USFDA clears Solara Active's Visakhapatnam facility. The US Food and Drug Administration has cleared Solara Active Pharma Sciences Ltd's new multipurpose active pharmaceutical ingredient manufacturing facility at Visakhapatnam, Andhra Pradesh, with no observation, the company said in an exchange filing.

Global Modest Fashion Weeks Finally arrives in Saudi Arabia and bring a theme

The 30-share BSE Sensex declined 491.90 points, or 0.84 per cent, to 58,152.92 for the week ended February 11.

Read more about Govt gives approval to four firms under PLI scheme for bulk drugs on Business Standard. The government has given approval to four waitlisted firms under the Production Linked Incentive (PLI) scheme for domestic manufacturing of bulk drugs, an official statement said on Monday.The Department of Pharmaceuticals had launched the PLI

Explore Now NEW DELHI: Solara Active, which has been rallying for three years now, has suddenly got its first ‘sell’ rating. As if on cue, the stock tanked 3.5 per cent in Mumbai trading on Thursday. The stock, which got listed at Rs 288 on June 27, 2018, hit a record high of Rs 1,859 on Wednesday, rising a solid 550 per cent, or 6.45 times, in less than three years. Six brokerages that cover the stock, all still have ‘buy’ ratings. But Antique Stock Broking initiated coverage on it on ...